
ãããŸã§èšã£ãŠå§å¡äŒNP(6/8)ã®æ€èšŒ
6æ8æ¥æŸéã®ããããŸã§èšã£ãŠå§å¡äŒNPããã芧ã«ãªããŸããã?
æšä»ã®ã¡ãã£ã¢ã®æ²¡èœã«
ãNetFlixããèŠãªãã
ããããã¬ããªããæšãŠã¡ãã£ãã
ãšããæ¹ãå€ããããããŸãããã
ç§ã¯ïŒðãyoutubeã§å°Ÿèº«æ°ã®çºèšã«å¯Ÿããæ¿ããè«äºãèŠãŠèå³ããããã®ã§TVerã§èŠãŠã¿ãŸããã
ããããŸã§èšã£ãŠå§å¡äŒãã§ã¯ïŒéå»ã«ãã³ããè¶çªã®ããããã宮沢å幞æ°ã®ã³ãã人工説ãåãäžããŠããŸããã
ãã¥ãŒã¹ãããã¥ã¡ã³ã¿ãªãŒãå
šãŠèåœå ±éã®NHKãã100åãŸãã§ããïŒè«ç¹ãããŒã¿ãæµ
ãã®ã¯åŠããŸããã
ã¡ãããšåæãããŠããŒã¿ãåºã«è§£èª¬ããŠããCBC倧ç³ã¢ãã®æ¹ãïŒãã»ã©èª¬åŸåããããŸãã
6æ8æ¥ã®æŸéã¯ïŒå°Ÿèº«èŠè«ïŒããïŒå°Ÿèº«èæ°ïŒå®®æ²¢å幞æ°ïŒæ£®ç°è±æ°ãã²ã¹ãã«ãæ°åã³ããç·æ¬ããšããããŒãã§ã³ããäºç®ãã³ããðãªã©ã«ã€ããŠãããŸã§èšãããŠããããšãç¹°ãè¿ããŠããã ãã§ãããããã§ãå°äžæ³¢ã§ïŒãããªããšãèšãçªçµã¯ãããŸã§ãªãã£ãã®ã§ïŒå°ãã¯çŸãããã¡ã«ãå±ãããããããŸããã
ðã§æãçãäžãã£ãŠããã®ã¯ïŒå°Ÿèº«æ°ã®ãã¯ã¯ãã³ã«ææé²æ¢å¹æã¯ããŸããªãã£ããçºèšã§ããã
ããã«å¯ŸãïŒðæšãã®ãã³ã³ããã¡ã¯ïŒãåãæãã ãããðã¯æåããéçåäºé²ã®ããã ããã"ããŸããªã"ã®ãš"å
šããªã"ã®ã¯å
šç¶éãããããšãïŒèŠãŠãŠçã
ããè¿ãã°ããã
ãã©ã³ãã®ãããã§ïŒãããŸã§"ãã¡ãåŽ"ãæé€ããŠããðå¥åº·è¢«å®³ã«é¢ããè«æãç¶ã
ãšå
¬éããïŒäŒå®¶ã®å®åã®ãè«æãåºãïœããéããªããªã£ãŠããŸãããïŒLab Leakã§ç±³åœæ¿åºãðã®éã®äžéšãèªããããã«ïŒããðæšãçéã¯è«ã®æ¯ã®ããã§ãã
ãŠããšã§ïŒãã®æŸéã®è©±é¡ã®äžéšãããŒã¿ã§æ€èšŒããŠã¿ãŸãããã
ïŒïŒãã¯ã¯ãã³ã«ææé²æ¢å¹æã¯ããŸããªãã£ãã
ãã€ãæžããŠãŸããïŒç¹äŸæ¿èªå ±åæžã§ã¯
ã»æ¬å€ã®SARS-CoV-2 ææäºé²å¹æã¯ãèšåºè©Šéšã§ã¯è©äŸ¡ãããŠããªããæ¬å€ãæ¥çš®ããå Žåã§ãã£ãŠããæææ¡å€§é²æ¢ã®ãããå¯éã坿¥åã³å¯éã®åé¿ãææŽããå³ãšãã±ããçã®åºæ¬çãªææäºé²å¯Ÿçã¯ç¶ç¶ããŠè¡ãå¿ èŠãããããã®ç¹ã¯å»çåŸäºè åã³è¢«æ¥çš®è ã«ãäŒããã¹ãã§ããã

ãšãªã£ãŠããŸãã
èšåºè©Šéšã§ïŒææäºé²å¹æã¯è©äŸ¡ããŠããªããšæåããæèšããŠãŸããïŒããããïŒ
ãæµ·å€C4591001 詊éšã¯SARS-CoV-2 ã®ææäºé²å¹æãè©äŸ¡ãã詊éšèšç»ã§ã¯ãªãã
ã®ã§ãã

ããã«ïŒ
åœå C4591005詊éšã§ã¯COVID-19çºçäºé²å¹æã«ã€ããŠã¯è©äŸ¡ãããŠããªãããè©Šéšæéäžã®COVID-19眹æ£ã蚺æã«é¢ããæ å ±ã¯æå®³äºè±¡ãšããŠåéããããšãšãããé¢é£ããå ±åã¯èªããããŠããªã

ã®ãšããïŒåœç¶ïŒæ¥æ¬ã§ã¯çºçäºé²å¹æããè©äŸ¡ãããŠããŸããã
ãŸãïŒ
æ°æçèŠå ã®å·®ãSARS-CoV-2 ã¯ã¯ãã³ã®æå¹æ§åã³å®å šæ§ã«åœ±é¿ããããšãèãããããããåœå ã§èšåºè©Šéšã宿œããæ¥æ¬äººè¢«éšè ã«ãããŠãã¯ã¯ãã³ã®æå¹æ§åã³å®å šæ§ãæ€èšããããšã¯å¿ èŠã

ãšæ¥æ¬äººã§ã®èšåºè©Šéšã®å¿ èŠæ§ãæèšããŠããã®ã«ïŒææäºé²ãçºçäºé²ãè©äŸ¡ããã«ïŒæµ·å€è©Šéšã®çµæã ãã§æå¹æ§ããããšçµè«ä»ããã®ã¯ïŒææ°ã©ãããæé ãšèšã£ãŠããããããããŸããã
ã§ã¯ïŒåœåïŒååŽçãå»ã¯ã©ã®èšã£ãŠãããææäºé²å¹æ95%ããšã¯äžäœã©ãããããã®ã§ããã?
èšåºè©Šéšã§ã¯ãCOVID-19 çºçã«å¯Ÿããã¯ã¯ãã³ã®æå¹æ§ãã詊éšããã®ã§ããïŒããããïŒæµ·å€â
¡/â
¢çžè©Šéšã§ã®ãçºçäºé²å¹æ95%ããææäºé²å¹æãšåœã£ããã®ã§ãããã1.8äžäººäžãã©ã»ãã§ãçºçè
162人(=çºçç0.88%)ãïŒäºé²å¹æ95%ã®ðæ¥çš®ã§çºçè
8人(çºçç=0.044%)ã«ãªãã ããšããããšã¯çµ¶å¯Ÿã«èšããŸãããã
ã€ãŸãïŒã³ãããã£ðã¯SARS-CoV-2ã®ææäºé²å¹æã®è©ŠéšããããŠããªãã®ã§ãããïŒææäºé²å¹æãæãã®ãç¡ãã®ãããïŒãã¡ã€ã¶ãŒãååŽçã尟身æ°ãç¥ããªãã£ãã£ãŠããšã§ãã
çºçè
æ°ã§ã¯å€§ããæ°ã«ãªããªãããïŒåœæ°ãææã§ç
œãããšãã§ããŸãããïŒãç¡çç¶ææã§æææ¡å€§ãããããã³ããŠçºä»€ããšããåãæã䜿ããªããªãã®ã§ïŒçºçäºé²å¹æã§ã¯ãªãææäºé²å¹æã«ããæ¿ããã®ãããããŸãããã
ãã®åŸïŒã95%ã®ææäºé²å¹æããå
¬èšããŠãã茩ãã8岿ã£ããéå£å
ç«ããðã¯2åããšãèšã£ãŠã茩ãïŒä»®ã«å¥Žãã«éšãããŠãããšããŠãïŒèªèº«ã®çºèšãè¬çœªã»èšæ£ããŠããã®ãèŠãããšããããŸããã(ãã®å€ãã¯éãè²°ã£ãŠ"æ¡ä»¶"ãšããŠãããçºä¿¡ããŠãã確信ç¯ã§ãããæªããšããæã£ãŠããªãã§ãããã)
æ¥æ¬åœæ°ã¯ïŒèªåã®çºèšã«è²¬ä»»ãæããïŒããããã誀æ
å ±ããæµåžããã¯ãºé£äžã«éšãããŠããã®ã§ããã
äœæ
ïŒæããªãã®?
ãŸãïŒæŸéã§ã¯ïŒå®®æ²¢æ°ã¯ïŒæ¥çš®è
ã®æ¹ããŠã€ã«ã¹æåºéãå€ããšçºèšããŠããŸããã
ã§ã¯ïŒå®éã«æ¥çš®åŸã®ææäºé²å¹æã¯ãã£ãã®ãïŒããŸãç¡ãã£ãã®ãïŒå
šç¶ç¡ãã£ãã®ãïŒãããšã广ãç¡ãã ãã§ãªãæ¥çš®è
ãææãåºããŠããã®ããããŒã¿ã§èŠãŠã¿ãŸãã
ãããæ¯ååºããŠããå³ã§ããïŒäžç®çç¶ã§ããã

å³ã®éãïŒ3åç®ä»¥éã¯ðæ¥çš®åæ°ãšã³ããéœæ§è
æ°ã¯å®å
šã«ã¿ã€ãã³ã°ãäžèŽãïŒæã£ããæææ¡å€§ã
ååŽçã¯ïŒ"äœæ
ã"ïŒçªç¶ïŒéœæ§è
ã®æ¥çš®æŽã調æ»ã»å
¬è¡šããªããªã£ããã(æ¥çš®æŽäžæãæªæ¥çš®ã«å«ããŠæªæ¥çš®è
ã®æ¹ãææããããŒã¿ãæé ãããããŠãŸããããïŒä»ã«ããããããšéœåã®æªãããšããã£ãã®ã§ãããã)ïŒæã£ããææãããšã¯æèšã§ããŸãããïŒå®®æ²¢æ°ã®èšãéãæ¥çš®è
ãæªæ¥çš®è
ããå€ãã®ãŠã€ã«ã¹ãæåºããã®ã§ããã°ïŒæ¥çš®è
ã¯ææããŠãèªèŠãç¡ãããè¡åå¶éãªã©ããïŒã©ãã©ãææãåºããŠãã£ããšèãããšçãéããŸãã
ææãäºé²ãã广ãªã©ç¡ãðãïŒãå®¶æãå®ãããããé«éœ¢è ãå®ãããããæãããã¯ã¯ãã³ããšèšã£ãŠæ¥æ¬äººã®åªããã«ä»ã蟌ãã§æãããçµæïŒããææãæ¡å€§ãïŒã³ããæžŠãé·åŒããïŒåäŸãã¡ã®ç掻ã奪ãïŒçµæžãæ¢ããŠãããšããã®ã宿 ã§ãã
2.ãéçåäºé²å¹æã
ãããæ¯ååºããŠããç¹äŸæ¿èªå ±åæžã«ããã°ïŒ
æ¬å€ã®COVID-19 ã®éçåæå¶å¹æã¯ç¢ºèªã§ããŠããªãã

ãšãªã£ãŠããŸãã
ã¡ãŒã«ãŒãååŽçã確èªã§ããŠããªãéçåäºé²å¹æãæããšèšã£ãã®ã¯ïŒãã£ãã誰ã§ãããããããããïŒæ¿åºã»ååŽçãèšè«çµ±å¶ãã¹ã
ããããã誀æ å ±ã
ã§ã¯ãªãã§ãã?
éçåäºé²ã®æç¡ãã¢ããã€ã¶ãªãŒããŒãè³æã®ããŒã¿ããæ€èšŒããŠã¿ããšïŒ

éç(377å)ããã®æ»äº¡63å
ç¡çç¶ã»è»œçããã®æ»äº¡1227å
ãšïŒéçè (377å)ã¯ç¡çç¶ã»è»œçãã亡ããªãæ¹(1227å)ãããæç¶å°ãªãããšãããããŸãã
人工åŒåžåšäœ¿çšç¶æ³ãèŠãŠãïŒãªãã¯ãã³ã®ç¬¬6波以éïŒéã§ç€ºããæ»äº¡è æ°ã¯ã©ãã©ãå¢ããŠããã®ã«ïŒèµ€ã§ç€ºããéçè æ°ã¯ã©ãã©ãæžã£ãŠããŸãã

以äžã®ããŒã¿ããïŒç¢ºãã«ïŒéçè
æ°ãæžãã广ã¯ããããã§ããïŒããã¯éçåãäºé²ããŠããããã§ã¯ãªãã§ãããã
ç¡çç¶ã»è»œçããéçåããéããªã亡ããªãæ¹ã倧å¢ããããã«éçè
æ°ãå°ãªãã ãã§ãããïŒãéçåäºé²å¹æãã§ã¯ãªããéçåããã«æ»äº¡ãã广ãã£ãŠããšã§ããããã§ããïŒå°Ÿèº«ãã?
ãã®ä»ïŒãã³ãããã¯æ¡çŽã®ä»¶ãïŒè±ç°çç±åæ°ãæ©æ¬åŸ¹æ°ãªã©ã®ã³ã¡ã³ããŒã¿ã®ã³ã¡ã³ããçªã£èŸŒã¿ã©ããæºèŒãªã®ã§ããïŒé·ããªããŸããã®ã§ïŒäžã€ã ãã
宮沢æ°ã®èšãããã«äººå·¥ãã©ããã§ä»åŸã®å¯ŸåŠæ³ã¯å
šãç°ãªããŸããïŒäººå·¥ãšçµè«ä»ããããã®ã¯äœå¹Žãå
ãªã®ã§ãããã
ããã©ïŒä»åŸããã³ãããã¯ã¯äººå·¥ç©ã§åŒãèµ·ããããŸãã
ãããŠïŒ"圌ã"ãåŒãèµ·ããåé¡ãšå¯Ÿçã¯ã»ããã§ãã
ä»ã®ãŸãŸã§ã¯ïŒäººå·¥ç©ã§ããã³ãããã¯ã ãããšå€§éšãããŠïŒå©ããéã¯çæ¯ã®è¬ç©æ¥çš®ãããªãïŒãšããã³ãããšå
šãåããã©ãŒãããã«åŠç¿èœåã®äœãæ¥æ¬äººã®å€ããåŒã£æãããŸãã
æ¢ã«äžçã®äººã
ã¯ïŒãã®ãã©ãŒããããåŠç¿ããã®ã§ïŒæ¬¡åã¯æåããæ¯é
å±€ãšå¯Ÿå³ããŠããã§ãããã
å¯ŸåŠæ³ã¯ãã³ãããã¯æ¡çŽã§å
šäœäž»çŸ©ã«åŸãããšã§ã¯ãªãïŒ"圌ã"ã®ã·ããªãªéãã«ç€ŸäŒãåããããªãããïŒäžçã®å®æ
ãç¥ãïŒäžçãæ¯é
ããããšããå
šäœäž»çŸ©ã«çãå£çµããŠæµæããŠããåãé€ãããšã§ãã
ãã®ããã«æã
ã«å¿
èŠãªã®ã¯æŠåšã§ãè¬ã§ããªãïŒäœããã£ãŠãé£ã¹ãŠããããã飿ã確ä¿ããããšïŒãããã ãã§ãªãçŸå®ç€ŸäŒã§æ
å ±ãå
±æã§ãããããã¯ãŒã¯ãæ§ç¯ããããšïŒãããŠäºæ«ãªããšã§ç
œã£ãŠããåæå·¥äœã«ä¹ããªãããšã§ãã
ãã³ãããã¯ã ãã§ãªãïŒéè屿©ãçŽäºãªã©ïŒ"圌ã"ã仿ããŠããéšåã¯åºæ¬ã®ãã©ãŒããããåãã§ãããïŒæŽå²ãåŠã¹ã°ïŒ"圌ã"ã®ããå£ãåãã£ãŠå¯ŸåŠããããšãã§ããŸãã
æŽå²ãåŠã³ïŒèªåã®é ã§èããããšãïŒãŸããŸãéèŠã«ãªã£ãŠããŸãã